Reinforced Pancreaticojejunostomy With or Without glubran2
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMinia University
About this trial
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Eligibility criteria
Qualifiers
All the patients undergoing pancreaticoduodenectomy for cancer
Patients able to give their informed consent
Disqualifiers
Unfit patients for surgery due to severe medical illness.
Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
Presence of distant metastasis .
Patients refused to participate in the study.
Trial design
Treatments tested in this trial
- Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2)
- Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2)
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov